| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Journal of Lipid Research, Vol 30, 1895-1906, Copyright © 1989 by Lipid Research, Inc.
ARTICLES |
D Applebaum-Bowden, P McLean, A Steinmetz, D Fontana, C Matthys, GR Warnick, M Cheung, JJ Albers and WR Hazzard
Department of Medicine, University of Washington School of Medicine, Seattle 98195.
To test whether estrogen can modulate the cholesterolemic response to an Occidental diet, six healthy postmenopausal women were studied for 84 days while ingesting a solid food diet of constant composition high in cholesterol content (995 mg/d). In the middle of the study, estrogen (17 alpha-ethinyl estradiol, 1 microgram/kg per day) was administered orally. Ingestion of the diet for the initial 28 days did not alter lipoprotein lipid or apolipoprotein (apo) levels. However, with just 4 days of estrogen use there were significant decreases in apoE (-36%), low density lipoprotein cholesterol (-26%), and postheparin plasma hepatic triglyceride lipase activity (HTGL) (-61%), and an increase in high density lipoprotein (HDL) triglyceride (72%). These changes persisted throughout the estrogen use. The percent change in HTGL with 4 days of estrogen correlated inversely with the percent change in HDL triglyceride (rs = -0.94). After 28 days of estrogen there were also significant increases in HDL cholesterol (21%), HDL2 cholesterol (42%), apoA-I (37%), and apoA-II (9%), and a decrease in apoB (-11%). The level of apoE at this juncture correlated inversely with the level of HDL cholesterol (rs = -0.90), and the levels of HTGL and apoA-I correlated with HDL2 cholesterol (rs = -0.89 and rs = 0.89, respectively). Thus, HTGL may play a role in both the early estrogen- related changes in HDL triglyceride and apoE and the late estrogen- related changes in HDL cholesterol, apoA-I, and apoA-II.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, M. J. Chapman, and M. Guerin Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects J. Lipid Res., March 1, 2008; 49(3): 635 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Barnett, M. N. Woods, S. Lamon-Fava, E. J. Schaefer, J. R. McNamara, D. Spiegelman, E. Hertzmark, B. Goldin, C. Longcope, and S. L. Gorbach Plasma Lipid and Lipoprotein Levels during the Follicular and Luteal Phases of the Menstrual Cycle J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 776 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-A. Phillips and J. Bernhard Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions J Natl Cancer Inst, February 5, 2003; 95(3): 190 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Jones, R. J. Schmidt, R. T. Pickard, P. S. Foxworthy, and P. I. Eacho Estrogen receptor-mediated repression of human hepatic lipase gene transcription J. Lipid Res., March 1, 2002; 43(3): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. YAFFE Estrogens, Selective Estrogen Receptor Modulators, and Dementia: What Is the Evidence? Ann. N.Y. Acad. Sci., December 1, 2001; 949(1): 215 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, S. Seshadri, R. C. Ellison, T. Heeren, and D. T. Felson Bone Mineral Density and Verbal Memory Impairment: Third National Health and Nutrition Examination Survey Am. J. Epidemiol., November 1, 2001; 154(9): 795 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. FRIEDLANDER and L. ALTMAN Carotid artery atheromas in postmenopausal women: Their prevalence on panoramic radiographs and their relationship to atherogenic risk factors J Am Dent Assoc, August 1, 2001; 132(8): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Callahan, W. J. Lipinski, F. Bian, R. A. Durham, A. Pack, and L. C. Walker Augmented Senile Plaque Load in Aged Female {beta}-Amyloid Precursor Protein-Transgenic Mice Am. J. Pathol., March 1, 2001; 158(3): 1173 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bravo, A. Cantafora, M. Avella, and K. M. Botham Metabolism of Chylomicron Cholesterol Is Delayed by Estrogen. An In Vivo Study in the Rat Experimental Biology and Medicine, February 1, 2001; 226(2): 112 - 118. [Abstract] [Full Text]
|
|
|
|
|
|
K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Seed, R. H Sands, M. McLaren, G. Kirk, and D. Darko The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women Fam. Pract., December 1, 2000; 17(6): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Wang, S. Q. Liao, R. S. Liu, C. Y. Liu, H. T. Chao, S. R. Lu, H. Y. Yu, S. J. Wang, and H. C. Liu Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study Neurology, June 13, 2000; 54(11): 2061 - 2066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yaffe, M. Haan, A. Byers, C. Tangen, and L. Kuller Estrogen use, APOE, and cognitive decline: Evidence of gene-environment interaction Neurology, May 23, 2000; 54(10): 1949 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Manly, C. A. Merchant, D. M. Jacobs, S. A. Small, K. Bell, M. Ferin, and R. Mayeux Endogenous estrogen levels and Alzheimer's disease among postmenopausal women Neurology, February 22, 2000; 54(4): 833 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lamon-Fava, J. M. Ordovas, and E. J. Schaefer Estrogen Increases Apolipoprotein (Apo) A-I Secretion in Hep G2 Cells by Modulating Transcription of the Apo A-I Gene Promoter Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2960 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. de Valk-de Roo, C. D.A. Stehouwer, P. Meijer, V. Mijatovic, C. Kluft, P. Kenemans, F. Cohen, S. Watts, and C. Netelenbos Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women : A 2-Year, Placebo-Controlled Study Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2993 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Rosenson, C. C. Tangney, and L. J. Mosca Hormone Replacement Therapy Improves Cardiovascular Risk by Lowering Plasma Viscosity in Postmenopausal Women Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1902 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hozumi, M. Kawano, T. Saito, and M. Miyata Effect of Tamoxifen on Serum Lipid Metabolism J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1633 - 1635. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Vincent-Viry, F. Schiele, R. Gueguen, K. Bohnet, S. Visvikis, and G. Siest Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study Clin. Chem., May 1, 1998; 44(5): 957 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Harnish, M. J. Evans, M. S. Scicchitano, R. A. Bhat, and S. K. Karathanasis Estrogen Regulation of the Apolipoprotein AI Gene Promoter through Transcription Cofactor Sharing J. Biol. Chem., April 10, 1998; 273(15): 9270 - 9278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yaffe, G. Sawaya, I. Lieberburg, and D. Grady Estrogen Therapy in Postmenopausal Women: Effects on Cognitive Function and Dementia JAMA, March 4, 1998; 279(9): 688 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Knopp and X. Zhu Multiple Beneficial Effects of Estrogen on Lipoprotein Metabolism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3952 - 3954. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Manning, I. J. Edwards, W. D. Wagner, J. D. Wagner, M. R. Adams, and J. S. Parks Effects of Contraceptive Estrogen and Progestin on the Atherogenic Potential of Plasma LDLs in Cynomolgus Monkeys Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1216 - 1223. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Wagner, D. C. Schwenke, L. Zhang, D. Applebaum-Bowden, J. D. Bagdade, and M. R. Adams Effects of Short-term Hormone Replacement Therapies on Low-Density Lipoprotein Metabolism in Cynomolgus Monkeys Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1128 - 1134. [Abstract] [Full Text]
|
|
|
|
|
|
E. A. Brinton Oral Estrogen Replacement Therapy in Postmenopausal Women Selectively Raises Levels and Production Rates of Lipoprotein A-I and Lowers Hepatic Lipase Activity Without Lowering the Fractional Catabolic Rate Arterioscler. Thromb. Vasc. Biol., March 1, 1996; 16(3): 431 - 440. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |
